
A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds. The treatment, called chimeric antigen receptor (CAR) T-cell therapy, is used to fight certain types of blood cancer — including leukemia and lymphoma — that have not responded to standard treatments. It involves… read on > read on >